- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03968367
To Study the Effect of Magnetic Activated Sperm Sorting on the Outcome of in Vitro Fertilization-embryo Transplantation (MASS)
May 28, 2019 updated by: Li-jun Ding
To Study the Effect of Magnetic Activated Sperm Sorting on the Outcome of in Vitro Fertilization-embryo Transplantation Among Patients With High DNA Fragmentation Index
Recent studies have evaluated the use of magnetic-activated sperm sorting (MASS) to reduce apoptotic spermatozoa and improve the outcome of infertile male with assisted reproductive technology (ART).
However, some results were inconsistent with above.
The sperm of male with abnormal semen analysis tend to be accompanied with high apoptotic and high DNA fragmentation index (DFI).
Hence, this study aimed at determining the efficiency of MASS in improving the clinical outcome of patients with high DFI).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patients will be recruited from our reproductive medicine center in Nanjing Drum towel Hospital, from July 2019 to July 2020.
After semen analysis and selection of infertile men with at least two abnormal sperm parameters and obtaining the informed consent of the patients according to the admission criteria, the patients who enter the project will be randomly divided into the control group (n=30) whose sperm will be screened by density differential centrifugation (DGC) with swim up, and the observation group will be screened by MASS, followed by DGC.
Then the procedure of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) will be performed.
Embryo transfer will be underwent according to the developmental speed and morphological characteristics of the embryo.
The clinical outcomes after transplantation will be followed up.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210008
- Recruiting
- Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patients were diagnostic as infertile according to 2007 WHO guidelines;
- DFI>25%.
Exclusion Criteria:
- With obvious female infertile factors;
- Sperm count <10 million;
- Chromosomal abnormalities in either or both of the couple;
- Loss of follow up or incomplete information of patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Magnetic activated sperm cell sorting for infertile man
A 0.5 mL aliquot of spermatozoa suspended in HTF-modified HEPES buffer, obtained either after sperm wash to remove the seminal plasma or after DGC, was centrifuged and the pellet (maximum of 107 cells) was resuspended in 80 uL of binding buffer with 20 uL of Annexin V-conjugated microspheres, both from the Annexin V microbead kit (Miltenyi Biotec, Huburn, CA, USA), for 15 min at room temperature.
After addition of 400 lL of binding solution, the suspension was placed in the separation column (MiniMACS, Miltenyi Biotec).
Labeled (apoptotic) cells were retained on the column and non-labeled (viable) cells passed through the column.
|
MACS is a technique which allows the spermatozoa with the best characteristics to be selected for use in assisted reproduction treatments.
This technique removes apoptotic spermatozoa - those which will die without achieving fertilisation - and selects the healthy ones, thus increasing the possibility of pregnancy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy rate
Time Frame: 2-3 months
|
Pregnancy rate was defined from posi tive blood HCG and ultrasonography findings showing at least one embryo with a foetal heart beat 5 weeks after transfer.
|
2-3 months
|
|
Implantation rate
Time Frame: 2-3 months
|
Implantation rate means the percentage of those embryos that implanted themselves into the uterine lining after having been transferred to the womb.
Fetal heartbeat can be visualized via ultrasound in order to definitely confirm the implantation of the embryo.
|
2-3 months
|
|
Live-birth rate
Time Frame: 1year
|
Live birth rate was defined as the number of deliveries that resulted in a live born neonate.
|
1year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 20, 2019
Primary Completion (ANTICIPATED)
April 30, 2020
Study Completion (ANTICIPATED)
July 19, 2020
Study Registration Dates
First Submitted
May 28, 2019
First Submitted That Met QC Criteria
May 28, 2019
First Posted (ACTUAL)
May 30, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 30, 2019
Last Update Submitted That Met QC Criteria
May 28, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SZ-2018-MASS1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Male
-
Szeged UniversityEnrolling by invitation
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
South Valley UniversityActive, not recruitingMale Infertility | OligoasthenozoospermiaEgypt
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Fecundis Lab SLRecruitingMale Infertility | Reproductive Issues | ICSI | Infertility (IVF Patients) | IVF OutcomesSpain
-
Jinling Hospital, ChinaRecruitingMale Infertility Due to HypospermatogenesisChina
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingMale Infertility With OATVietnam
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Reproductive Medicine Associates of New JerseyTerminated
Clinical Trials on Magnetic activated sperm sorting
-
Universitair Ziekenhuis BrusselUnknown
-
Ganin Fertility CenterCompleted
-
Instituto de Investigación Sanitaria y Biomédica...Completed
-
CREA Medicina de la Reproducción SLRecruitingIntracytoplasmic Sperm Injection | Sperm | MicrofluidicsSpain
-
Hanoi Medical UniversityCompletedMale Infertility | In Vitro Fertilization (IVF) | Sperm DNA FragmentationVietnam
-
Maltepe UniversityCompletedIVF | ICSI | Reduced Sperm Motility | Astheno TeratozoospermiaTurkey
-
Weill Medical College of Cornell UniversityRecruiting
-
Bezmialem Vakif UniversityYeditepe University HospitalCompletedMale Infertility | Infertility, MaleTurkey
-
Bezmialem Vakif UniversityUnknownInfertility, Male | Infertility UnexplainedTurkey
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeCompletedGender Ratio of ICSI OutcomeEgypt